A Study of Macupatide (LY3532226) and Eloralintide (LY3841136)
Phase 2
200
about 1.6 years
18–75
22 sites in AZ, GA, NJ +5
Why this study is shown
What this study is about
Researchers are testing macupatide and eloralintide, alone or in combination, to see if they help people with obesity or overweight who also have type 2 diabetes lose weight. The trial will last about 48 weeks.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Eloralintide
- 2.Take Eloralintide Placebo
- 3.Take Macupatide
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Percent Change from Baseline in Body Weight
Secondary: Change from Baseline in Body Mass Index (BMI), Change from Baseline in Fasting Glucose, Change from Baseline in Hemoglobin A1c (HbA1c)
Endocrinology